Skip to main content

KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · IEX Real-Time Price · USD
16.26 -0.54 (-3.21%)
Oct 25, 2021 12:46 PM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is May - April.
Year2020201920182017201620152014201420132012
Revenue
012.6916.138.391.52.1300.030.421.54
Revenue Growth
--21.31%92.13%458.11%-29.49%---93.01%-73.02%-
Gross Profit
012.6916.138.391.52.1300.030.421.54
Selling, General & Admin
16.6413.0310.938.8611.182.651.613.411.41.41
Research & Development
41.2940.1935.0218.2412.6714.668.298.294.231.96
Operating Expenses
57.9253.2245.9527.123.8417.319.8911.715.633.37
Operating Income
-57.92-40.53-29.82-18.71-22.34-15.18-9.89-11.68-5.22-1.83
Interest Expense / Income
00000001.080.410.26
Other Expense / Income
-11.68-11.29-9.13-2.9-3.74-3.75-2.670.60.06-0.04
Pretax Income
-46.24-29.24-20.69-15.81-18.6-11.44-7.23-13.36-5.68-2.05
Income Tax
0-0.120.120000000
Net Income
-46.24-29.12-20.82-15.81-18.6-11.44-7.23-13.36-5.68-2.05
Preferred Dividends
0000000000.11
Net Income Common
-46.24-29.12-20.82-15.81-18.6-11.44-7.23-13.36-5.68-2.16
Shares Outstanding (Basic)
19181510510000
Shares Outstanding (Diluted)
19181510510000
Shares Change
7.58%17.69%46.11%122.13%685.86%124.52%501.93%44.79%0.45%-
EPS (Basic)
-2.42-1.64-1.38-1.53-4.47-26.17-34.94-305.34-187.88-71.96
EPS (Diluted)
-2.42-1.64-1.38-1.53-4.47-26.17-34.94-305.34-187.88-71.96
Free Cash Flow Per Share
-1.58-2.54-2.480.89-5.12-22.27-24.66-260.83-161.36-64.02
Gross Margin
-100.00%100.00%100.00%100.00%100.00%-100.00%100.00%100.00%
Operating Margin
--319.41%-184.91%-222.84%-1485.31%-711.72%--40265.52%-1256.87%-119.18%
Profit Margin
--229.44%-129.08%-188.29%-1236.90%-536.15%--46065.52%-1368.19%-133.49%
Free Cash Flow Margin
--354.89%-232.19%108.78%-1582.18%-617.30%--39351.72%-1174.94%-125.23%
Effective Tax Rate
0.00%0.42%-0.60%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBITDA
-45.59-28.72-20.31-15.63-18.56-11.4-7.19-12.22-5.25-1.76
EBITDA Margin
--226.28%-125.96%-186.14%-1234.24%-534.60%--42148.28%-1264.10%-114.37%
EBIT
-46.24-29.24-20.69-15.81-18.6-11.44-7.23-12.28-5.27-1.8
EBIT Margin
--230.42%-128.31%-188.29%-1236.90%-536.15%--42334.48%-1270.60%-116.84%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).